Search Results - "Lünemann, JD"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Intravenous immunoglobulin in neurology—mode of action and clinical efficacy by Lünemann, Jan D., Nimmerjahn, Falk, Dalakas, Marinos C.

    Published in Nature reviews. Neurology (01-02-2015)
    “…Key Points Intravenous immunoglobulin (IVIg) is established for the treatment of several inflammatory neurological diseases, including Guillain–Barré syndrome,…”
    Get full text
    Journal Article
  2. 2

    Antiviral immune response in patients with multiple sclerosis and healthy siblings by Comabella, M., Montalban, X., Horga, A., Messmer, B., Kakalacheva, K., Strowig, T., Caballero, E., Münz, C., Lünemann, JD

    Published in Multiple sclerosis (01-03-2010)
    “…The objective of this study was to determine the immune responses to candidate viral triggers of multiple sclerosis in patients and healthy siblings raised in…”
    Get full text
    Journal Article
  3. 3

    Efficacy of Intravenous Immunoglobulin in Neurological Diseases by Lünemann, Jan D., Quast, Isaak, Dalakas, Marinos C.

    Published in Neurotherapeutics (01-01-2016)
    “…Owing to its anti-inflammatory efficacy in various autoimmune disease conditions, intravenous immunoglobulin (IVIG)—pooled IgG obtained from the plasma of…”
    Get full text
    Journal Article Book Review
  4. 4
  5. 5

    Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)antigen-Specific T Cells by Lunemann, Jan D, Waiczies, Sonia, Ehrlich, Stefan, Wendling, Uwe, Seeger, Bibiane, Kamradt, Thomas, Zipp, Frauke

    Published in The Journal of immunology (1950) (15-05-2002)
    “…TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily, induces apoptosis in susceptible cells, which can be both malignant and…”
    Get full text
    Journal Article
  6. 6

    Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study by Schmierer, Klaus, Altmann, Daniel R, Kassim, Nadja, Kitzler, Hagen, Kerskens, Christian M, Doege, Claudia A, Aktas, Orhan, Lünemann, Jan D, Miller, David H, Zipp, Frauke, Villringer, Arno

    Published in Multiple sclerosis (01-04-2004)
    “…In spite of marked disability, patients with primary progressive multiple sclerosis (PPMS) display smaller lesion volumes on conventional magnetic resonance…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Elevated Bcl-X L levels correlate with T cell survival in multiple sclerosis by Waiczies, Sonia, Weber, Alexandra, Lünemann, Jan D., Aktas, Orhan, Zschenderlein, Rolf, Zipp, Frauke

    Published in Journal of neuroimmunology (01-05-2002)
    “…T cell resistance towards apoptotic elimination by activation-induced cell death (AICD) might be a crucial pathogenic feature of multiple sclerosis (MS). Since…”
    Get full text
    Journal Article
  9. 9

    Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis by LÜNEMANN, Jan D, ZARMAS, Silvia, PRIEM, Susanne, FRANZ, Juliane, ZSCHENDERLEIN, Rolf, ABERER, Elisabeth, KLEIN, Rolf, SCHOULS, Leo, BURMESTER, Gerd R, KRAUSE, Andreas

    Published in Journal of clinical microbiology (01-03-2001)
    “…To further investigate the pathogenic potential of different Borrelia burgdorferi genospecies, specimens from 27 patients with different manifestations of Lyme…”
    Get full text
    Journal Article
  10. 10

    Cross-sectional and longitudinal analysis of myelin-reactive T cells in patients with multiple sclerosis by LÜNEMANN, Jan D, RÜCKERT, Sandra, KERN, Florian, WENDLING, Uwe, VAN DER ZEE, Ruud, VOLK, Hans D, ZIPP, Frauke

    Published in Journal of neurology (01-09-2004)
    “…Activated myelin-specific T cells are thought to mediate inflammatory tissue damage in multiple sclerosis (MS). Applying a large panel of myelin antigens, we…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Heterogeneity of Borrelia burgdorferi: etiopathogenetic relevance and clinical implications by Lünemann, J D, Krause, A

    Published in Zeitschrift für Rheumatologie (01-04-2003)
    “…Of the ten different species of Borrelia (B.) burgdorferi sensu lato which have been characterized to date, only B. burgdorferi sensu stricto, B. garinii and…”
    Get full text
    Journal Article
  13. 13

    Multiple sclerosis coinciding with Machado-Joseph disease by Röhl, J E, Lünemann, J D, Zimmer, C, Zschenderlein, R, Valdueza, J M

    Published in Neurological sciences (01-06-2005)
    “…Although inflammatory demyelination is considered to be the key feature in multiple sclerosis (MS) pathogenesis, histopathological investigations and MRI…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Immunotherapy of chronic inflammatory demyelinating polyneuropathy by Lünemann, J D, Prass, K, Zschenderlein, R

    Published in Fortschritte der Neurologie, Psychiatrie (01-12-2004)
    “…Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated disease of the peripheral nervous system with an estimated prevalence…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Norepinephrine inhibits energy metabolism of human peripheral blood mononuclear cells via adrenergic receptors by Lünemann, J D, Buttgereit, F, Tripmacher, R, Baerwald, C G, Burmester, G R, Krause, A

    Published in Bioscience reports (01-10-2001)
    “…Previous studies demonstrated that the adaptive response to stressors and inflammatory signals involves the activation of the autonomous [corrected] nervous…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20